The KCNJ5 gene gives instructions for a channel that helps adrenal gland cells control the movement of potassium and the release of aldosterone, a hormone that balances salt, potassium, and blood pressure. When this channel does not work normally, the adrenal glands may make too much aldosterone. This can lead to high blood pressure, low potassium, muscle weakness, or tiredness. Certain variants in the KCNJ5 gene are linked to inherited forms of primary aldosteronism and some adrenal growths.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes carry the information needed to make proteins, which are the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they take place, and how active they are. Together, genes affect how the body grows and functions, and they can also shape how you respond to food, stress, and medications. To go into this topic in more detail, you can read more in the LearnHub.
Overview
KCNJ5Gene function
What if the gene works
The KCNJ5 gene helps form a potassium channel, a tiny pore that controls potassium movement in some cells. This supports steady electrical activity and helps regulate aldosterone, a hormone that controls salt, potassium, and blood pressure.
Risk
What if the gene does not work
Variants in the KCNJ5 gene can raise aldosterone too much, often leading to primary aldosteronism with high blood pressure and sometimes low potassium. Milder and more severe variants can affect when features begin and how strongly they show up.
Treatment
What does that mean for your treatment
No KCNJ5-specific treatment or drug choice is currently established. Care still follows standard treatment for primary aldosteronism, and the KCNJ5 gene is being studied as a biomarker that may help predict features of aldosterone-producing adrenal tumors and response to treatment.
Conditions associated with KCNJ5
Gene function
What if the gene works
Many cells need a steady electrical charge to send signals, contract, or release hormones at the right time. Understanding how the KCNJ5 gene works helps explain how this balance is maintained. It helps make part of a potassium channel used in heart and adrenal cells.
The KCNJ5 gene helps build a channel that lets potassium move across the cell membrane. This controlled flow helps cells keep their electrical state steady.
By letting potassium move at the right moments, this gene helps set a cell's usual electrical charge at rest. That steady starting point helps certain cells respond to signals in a controlled way.
In heart cells, the KCNJ5 protein helps channels respond to vagus nerve signals, which are part of the body's resting state. This can gently slow the heartbeat and support normal beat to beat adjustment.
In adrenal cells, channels that include the KCNJ5 protein help link electrical signals to aldosterone release. Aldosterone is a hormone that helps control salt balance, blood volume, and blood pressure.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help explain normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant can more clearly change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KCNJ5 gene can change how the channel protein is built or how selectively it handles potassium, and some create an abnormal sodium leak. This can make adrenal cells more electrically active and raise aldosterone release. Stronger channel-disrupting variants are often linked to earlier or more pronounced disease than milder variants. In short, how KCNJ5 variants affect potassium channel function depends on the specific DNA change and how much it alters channel stability, opening, or ion selectivity.
How variants are linked to conditions
Inherited pathogenic variants in the KCNJ5 gene can cause familial hyperaldosteronism type III, a form of primary aldosteronism that often appears with high blood pressure at a young age and may also cause low potassium. Acquired KCNJ5 gene variants linked to primary aldosteronism are also found in some aldosterone producing adrenal tumors.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are widely found in the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KCNJ5, risk is mainly shaped by the specific gene change itself, especially in rare inherited forms that can cause high aldosterone levels and early high blood pressure. There is not enough evidence to say that lifestyle changes lower KCNJ5-related genetic risk, although blood pressure checks and follow-up can help catch problems early.
Inheritance of KCNJ5 variants
For people asking how KCNJ5 gene variants are inherited, the well-established inherited pattern for KCNJ5-related familial hyperaldosteronism type III is autosomal dominant. This means a parent carrying a disease-causing variant in the KCNJ5 gene can pass it to a child with a 50% chance in each pregnancy, regardless of the child’s sex. Some people with this condition have a new, de novo variant in the KCNJ5 gene that was not inherited from either parent.
What does my KCNJ5 result mean for my family?
For the inherited form linked to the KCNJ5 gene, close relatives such as parents, brothers, sisters, and children may also carry the same gene change and could have high aldosterone, which can lead to high blood pressure at a young age. In many families, each child of someone with the variant has a 1 in 2 chance of inheriting it. Some KCNJ5 changes happen new in one person, so a parent does not always have the same variant.
Genetic information
Genetic testing
How you find out about variants
KCNJ5 genetic testing looks for variants in the KCNJ5 gene using a blood or saliva sample, and sometimes adrenal tissue after surgery. A lab reads the DNA and checks for changes that may help explain inherited high aldosterone or a hormone producing adrenal growth. Results can show whether a variant was found, not found, or needs more interpretation.
When should I consider getting a genetic test?
Genetic testing for the KCNJ5 gene may be worth considering when high blood pressure starts young, runs strongly in a family, or comes with low potassium and signs of too much aldosterone, a hormone that raises blood pressure. It can also help clarify some cases of inherited primary aldosteronism.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies by the condition and the specific type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This is common and helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. In practice, genetics is one part of the picture, along with age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect responses to medications. It studies connections between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the KCNJ5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice, so general questions about medicines or new symptoms are best discussed with your doctor. Research on KCNJ5 mostly involves certain adrenal gland growths, where gene changes may affect response to some treatments, but this has not become standard prescribing guidance.
History
The KCNJ5 gene entered clinical genetics in a meaningful way when researchers linked it to some forms of primary aldosteronism, a hormone condition that can raise blood pressure. In 2011, scientists reported KCNJ5 variants in aldosterone producing adrenal tumors, helping explain why some people developed this condition. Soon after, inherited KCNJ5 variants were identified in families with a rare form of early onset primary aldosteronism. From these first observations, research expanded steadily. These findings changed how doctors and researchers viewed certain adrenal hormone disorders, moving them from a broad clinical label toward more precise genetic subtypes. Over time, KCNJ5 became an important gene in the history of endocrine genetics and in the study of hormone related high blood pressure.